Thiazolidinediones and cardiovascular outcomes in type 2 diabetes Reply

被引：0
|
作者：
Singh, S. [1 ]
Furberg, C. D. [1 ]
机构：
[1] Wake Forest Univ, Winston Salem, NC 27109 USA
来源：
HEART | 2009年 / 95卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：332 / 332
页数：1
相关论文
共 50 条
  • [1] Thiazolidinediones and cardiovascular outcomes in type 2 diabetes
    Singh, Sonal
    Furberg, Curt D.
    HEART, 2009, 95 (01) : 1 - 3
  • [2] Type 2 diabetes, thiazolidinediones, and cardiovascular risk
    Taylor, Clare
    Hobbs, F. D. Richard
    BRITISH JOURNAL OF GENERAL PRACTICE, 2009, 59 (564): : 520 - 524
  • [3] Thiazolidinediones and clinical outcomes in type 2 diabetes
    Retnakaran, Ravi
    Zinman, Bernard
    LANCET, 2009, 373 (9681): : 2088 - 2090
  • [4] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes REPLY
    Zinman, Bernard
    Lachin, John M.
    Inzucchi, Silvio E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11): : 1094 - 1094
  • [5] Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes reply
    Husain, Mansoor
    Donsmark, Morten
    Bain, Stephen C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 2076 - 2077
  • [6] Thiazolidinediones and cardiovascular outcomes in older patients with diabetes
    Lipscombe, Lorraine L.
    Gomes, Tara
    Levesque, Linda E.
    Hux, Janet E.
    Juurlink, David N.
    Alter, David A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (22): : 2634 - 2643
  • [7] Comment: Thiazolidinediones in Type 2 Diabetes: A Cardiology Perspective REPLY
    Khanderia, Ujjaini
    Pop-Busui, Rodica
    Eagle, Kim
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (02) : 392 - 393
  • [8] Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
    Papaetis, Georgios S.
    Orphanidou, Dora
    Panagiotou, Themistoklis N.
    CURRENT DRUG TARGETS, 2011, 12 (10) : 1498 - 1512
  • [9] Introduction: the role of the thiazolidinediones in the cardiovascular risk management of type 2 diabetes
    Barnett, AH
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 : S1 - S3
  • [10] A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications
    Molavi, Behzad
    Rassouli, Negah
    Bagwe, Suveer
    Rasouli, Neda
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (06) : 967 - 973
12345